在急性髓性白血病中,DNMT3B控制增强器相关的染色素和细胞循环网络
Arundhati Chavan1, Pritam Biswas1, Kimberly Stephens2
1Division of Hematology/Oncology, Department of Pediatrics, Arkansas Children's Research Institute, University of Arkansas for Medical Sciences, Little Rock, AR 72202, USA.
Cancers
|March 14, 2026
概括
在急性髓性白血病 (AML) 中,DNMT3B的过度表达驱动了影响细胞周期和细胞亡的表观遗传变化. 向DNMT3B可以提高对BCL2抑制剂的敏感性,为高风险的AML提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 在急性髓性白血病 (AML) 中,DNMT3B过度表达,并与预后不佳有关.
- 与DNMT3A不同,DNMT3B突变很少见,这表明表观遗传失调.
- 在AML中DNMT3B过度表达的确切作用和影响尚未完全理解.
研究的目的:
- 研究DNMT3B在AML中的过度表达的表观遗传机制和下游影响.
- 使用纳纳米辛A (NanA) 作为探针来研究DNMT3B的功能.
- 探索DNMT3B在调节细胞增殖,细胞亡和药物敏感性方面的作用.
主要方法:
- 对BeatAML,TCGA和BLUEPRINT群体进行综合分析.
- 多原子分析包括RNA-seq,DNA甲基化,ATAC-seq和蛋白质组学.
- 使用纳纳米辛A (NanA) 干扰DNMT3B活性在AML模型中的功能性研究.
主要成果:
- DNMT3B的过度表达与增强剂相关的染色质激活相关,特别是在CEBPA和NPM1突变AML中.
- 纳纳米辛A诱导了显著的表观基因组重塑,改变了染色质的可访问性和DNA甲基化.
- 干扰DNMT3B导致细胞循环再分配,细胞亡的增加和细胞亡调节者的改变表达 (例如,NOXA,PUMA,BCL2,MCL1).
- 联合DNMT3B抑制和BCL2抑制在DNMT3B高AML中显示出协同性细胞毒性.
结论:
- DNMT3B作为AML的上下文依赖表观遗传调节剂,影响染色质组织,增殖和亡抵抗.
- DNMT3B导向的表观遗传调制重塑了调节网络,并增强了对venetoclax的敏感性.
- 由DNMT3B治理的网络代表了高风险洗钱LAM治疗的潜在共同准策略.
相关概念视频
02:23Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
02:23Master Transcription Regulators
8.0K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
02:15M-Cdk Drives Transition Into Mitosis
6.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K
01:23Negative Regulator Molecules
38.8K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
02:38Mitogens and the Cell Cycle
8.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K